In a recent SEC filing, Sarah Krepp, the Chief Human Resource Officer at Liquidia Corp, reported significant stock transactions. This filing is noteworthy as it highlights Krepp's active role in managing her equity holdings within the company.

Liquidia Corp, based in Morrisville, North Carolina, operates in the pharmaceutical preparations sector. The company is primarily engaged in developing innovative treatments and therapies. Liquidia is publicly traded under the ticker symbol LQDA.

The filing, dated October 13, 2026, reveals that Krepp acquired 3,178 shares of Liquidia common stock on October 9, 2026, and sold 5,245 shares on October 12, 2026, at a price of $28.48 per share. Following these transactions, Krepp now owns a total of 115,241 shares of common stock. Additionally, she holds 28,609 unvested restricted stock units (RSUs) from various grants.

According to the filing, Krepp's recent stock transactions were executed as part of a Rule 10b5-1 plan, which allows executives to set up a predetermined schedule for buying or selling shares to avoid accusations of insider trading. This plan was adopted on December 15, 2023.

The impact of Krepp's transactions may extend beyond her personal holdings. As the pharmaceutical industry continues to evolve, the way companies manage executive compensation and stock ownership is under scrutiny. Liquidia's practices could serve as a model for other firms in the sector, particularly regarding transparency and compliance with SEC regulations.

Looking ahead, further filings may provide additional insights into Krepp's ongoing stock management and Liquidia's strategic direction. The filing does not specify what happens next regarding these transactions.